Are you developing antibody-drug conjugates, antibody-oligonucleotide conjugates, or other next-generation antibody therapeutics? Join us on June 24, 2026 at 10 a.m. PT, 1 p.m. ET for our webinar, "Engineered for Impact: Unlocking the Power of Recombinant Antibodies in Next-Gen Therapeutics." In this webinar, you will learn about how recombinant antibody platforms improve reproducibility and scalability, enable precise site-specific conjugation for ADCs and AOCs, and reduce development risk with well-defined, engineerable reagents. Register now to save your spot for the live webinar.
Too busy to attend? Don’t worry. Register now and we will send you a link to the webinar on-demand right after the live event. Registrants who attend the live webinar or listen to the on-demand version will receive a certificate of attendance.
We hope to see you then.
Best,
